Newsroom | Takeda Pharmaceuticals U.S.A., Inc

RSS Feeds

December 17, 2012
Takeda to Sell Non-Colcrys URL Pharma, Inc. Generic Business to Sun Pharmaceutical
December 12, 2012
FDA Accepts Takeda and Lundbeck’s Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
November 13, 2012
Takeda’s Deerfield Campus Ranked Among Chicago’s Top 100 Workplaces in 2012
November 1, 2012
Affymax and Takeda Announce Analyses from OMONTYS® (peginesatide) Injection Phase 3 Dialysis Studies Presented at 2012 American Society of Nephrology Meeting
October 22, 2012
Takeda Partners with Museum of Science and Industry on Education Initiatives
October 16, 2012
Affymax and Takeda Announce OMONTYS® Data Presentations at the American Society of Nephrology Kidney Week 2012
October 5, 2012
Takeda Cares Day Supports Local Charities
October 4, 2012
Takeda to Acquire LigoCyte Pharmaceuticals, Inc.
October 1, 2012
Takeda and Lundbeck Announce the U.S. Submission of a New Drug Application for Vortioxetine, an Investigational Drug for the Treatment of Major Depressive Disorder
September 25, 2012
U.S. Food and Drug Administration Grants Priority Review Status to AMITIZA® (lubiprostone) Submission Seeking Approval for Treatment of Opioid-induced Constipation
September 5, 2012
American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
August 8, 2012
Takeda and Affymax Announce Supply Agreement for Omontys® (peginesatide) Injection with U.S. Renal Care, Inc.
July 27, 2012
Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
June 19, 2012
Edarbyclor (azilsartan medoxomil and chlorthalidone) Head-to-Head Data Published in Hypertension
June 4, 2012
Takeda Completes Acquisition of URL Pharma, Inc.
May 2, 2012
Chef Spike Mendelsohn Dishes on How to Turn Down the Heat on Acid Reflux Disease
April 25, 2012
Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes Investigational Therapies Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone
April 11, 2012
Takeda to Acquire URL Pharma
March 27, 2012
Affymax and Takeda Announce FDA Approval Of Omontys® (peginesatide) Injection For the Treatment of Anemia Due To Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
February 26, 2012
Phase 2 Data of Takeda’s Investigational GPR40 Agonist, Published in The Lancet, Demonstrated Improved Glycemic Control in Patients with Type 2 Diabetes
February 6, 2012
EDARBYCLOR (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension

News and Press Releases 2012